Affymetrix - Breast cancer
  • Home
    • FAQ
    • Legal
  • Affymetrix
    • Breast
    • AML
    • Colon
    • DLBCL
    • Gastric
    • GBM
    • Lung
    • Myeloma
    • Ovarian
    • Pancreas
    • Prostate
  • RNAseq
    • AML
    • Bladder
    • Breast - TCGA
    • Breast - GSE96058
    • Colon
    • Gastric
    • GBM
    • Head & neck
    • Liver
    • LGG
    • Lung
    • Melanoma
    • Ovarian
    • Pan-cancer
    • Pancreas
    • Prostate
    • RCC
  • DNA
    • Metabric DNA
    • Impact DNA
    • Pancancer DNA
  • Other
    • Metabric mRNA
    • Breast miRNA
    • Liver (Illumina)
    • Liver miRNA
    • miRNA pan-cancer
    • Pancreas (Agilent)
    • Breast Protein
    • Custom plot
    • Immunotherapy (v.2023)
    • Immunotherapy (v.2024)
    • Immunotherapy (v.2025)
 

Login



What is the KM plotter?

The KM plotter is capable to assess the effect of any gene or gene combination on survival in breast, ovarian, lung, gastric, colon, prostate, GBM, LGG, melanoma, DLBCL, RCC, AML, and 14 other tumor types using over 50,000 samples measured using gene arrays, RNA-seq or next generation sequencing (for mutation data).

KM-plot Private Edition

Commercial entities: the private version is provided for commercial entities and our collaboration partners. The private version includes:
- custom analysis options
- additional datasets
- previous versions
- user support
- analysis history
- and more

Commercial organizations are subject to the Terms of Use they have licensed. Please contact us at gyorffy@kmplot.com to obtain a license.

KM-plot Academic Edition

Academic researchers: provided that the original publications are properly cited, the use of https://www.kmplot.com is free for scientific projects. Please see the complete Terms of use in the academic version of the KM-plotter.

 

Contact :: Copyright (C) 2009-2025.